Klinikverbund Kempten-Oberallgäu gGmbH
Kempten, Germany
General hospital in Kempten, Bavaria
Robert-Weixler-Straße 50, 87439 Kempten (Allgäu)
About Klinikverbund Kempten-Oberallgäu gGmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Jiangsu HengRui Medicine Co., Ltd.
1
Prof. Wolfgang Janni
1
Clinical Trials at Klinikverbund Kempten-Oberallgäu gGmbH
During the past decade, Klinikverbund Kempten-Oberallgäu gGmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy
2020-09-11
2023-10-31
Active, not recruiting
151
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
2022-04-27
2026-04-01
Recruiting
300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikverbund Kempten-Oberallgäu gGmbH"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinikverbund Kempten-Oberallgäu gGmbH
According to Clinical.Site data, the most researched conditions in "Klinikverbund Kempten-Oberallgäu gGmbH" are
"HER2 Exon 20 Mutation" (1 trials), "HER2-negative Metastatic Breast Cancer" (1 trials), "Hormone Receptor-positive Metastatic Breast Cancer" (1 trials) and "Non-squamous NSCLC" (1 trials). Many other conditions were trialed in "Klinikverbund Kempten-Oberallgäu gGmbH" in a lesser frequency.
Clinical Trials Intervention Types at Klinikverbund Kempten-Oberallgäu gGmbH
Most popular intervention types in "Klinikverbund Kempten-Oberallgäu gGmbH" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials), "Docetaxel" (1 trials) and "Pyrotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikverbund Kempten-Oberallgäu gGmbH
The vast majority of trials in "Klinikverbund Kempten-Oberallgäu gGmbH" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikverbund Kempten-Oberallgäu gGmbH
Currently, there are NaN active trials in "Klinikverbund Kempten-Oberallgäu gGmbH".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Klinikverbund Kempten-Oberallgäu gGmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikverbund Kempten-Oberallgäu gGmbH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".